Iksuda Therapeutics exercises licensing rights from University of Goettingen
Agreement covers protein-alkylating, tumour-activated pro-drug payload series for ADC development
14th October 2020
Latest news
Redhill expands manufacturing for COVID-19 candidate
Company signs deals with two specialist pharmaceutical manufacturers
14th October 2020
J&J’s COVID-19 vaccine trial paused on safety concerns
Participant in phase III study developed unexplained illness
14th October 2020
RPS calls for prevention of counterfeit medicines in UK’s supply chain
In a letter to Health Secretary Matt Hancock the RPS called for urgent action
13th October 2020
UK biotech companies raise over £1bn in record quarter
Funds raised in equity finance between June and August 2020
13th October 2020
Sanofi’s Dupixent reduces severe asthma attacks in children
Biologic therapy hit primary and all key secondary endpoints in phase III
13th October 2020
Bavencio, Imbruvica among latest SMC decisions
The committee accepted a number of drugs through the PACE process
13th October 2020
ViiV posts positive long-term data for two-drug HIV regimen Dovato
Dovato demonstrated non-inferior efficacy compared to TAF-based regimens
12th October 2020
BMS’ Zeposia hits the mark in ulcerative colitis
Oral S1P receptor modulator hit both primary endpoints in a phase III trial
12th October 2020
Pfizer’s Ibrance flunks early breast cancer trial
Therapy failed to improve invasive disease-free survival in high-risk patients
12th October 2020
AZ’s long-acting COVID-19 antibody moves into phase III
Two trials will involve over 6,000 participants at sites in and outside the US
12th October 2020
Neuroblastoma UK welcomes advancement of potential new treatment
Fadraciclib has passed safety trials and shown early efficacy
9th October 2020
Amgen announces NHS collaboration aiming to tackle high cholesterol
Partnership will aim to prevent cardiovascular events across the North West Coast of England
9th October 2020
London universities join forces to ramp up COVID-19 testing
Testing Alliance created to offer 20,500 extra coronavirus tests a day
9th October 2020
European Commission scores 200 million doses of J&J’s potential COVID-19 vaccine
Advance purchase agreement follows initial exploratory talks
9th October 2020
